Antifungal susceptibility of 175Aspergillusisolates from various clinical and environmental sources
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Antifungal susceptibility of 175Aspergillusisolates from various clinical and environmental sources
Authors
Keywords
-
Journal
MEDICAL MYCOLOGY
Volume 54, Issue 7, Pages 740-756
Publisher
Oxford University Press (OUP)
Online
2016-05-04
DOI
10.1093/mmy/myw024
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- In VitroActivity of Amphotericin B AgainstAspergillus terreusIsolates from Different Countries and Regions
- (2014) A.M. Tortorano et al. JOURNAL OF CHEMOTHERAPY
- Molecular screening of 246 Portuguese Aspergillus isolates among different clinical and environmental sources
- (2014) R. Sabino et al. MEDICAL MYCOLOGY
- Evaluation of Etest Performed in Mueller–Hinton Agar Supplemented with Glucose for Antifungal Susceptibility Testing of Clinical Isolates of Filamentous Fungi
- (2014) E. Pinto et al. MYCOPATHOLOGIA
- Multi-Resistant Aspergillosis due to Cryptic Species
- (2014) Susan Julie Howard MYCOPATHOLOGIA
- Antifungal Susceptibility Profile of Cryptic Species of Aspergillus
- (2014) Ana Alastruey-Izquierdo et al. MYCOPATHOLOGIA
- Population-Based Survey of Filamentous Fungi and Antifungal Resistance in Spain (FILPOP Study)
- (2013) A. Alastruey-Izquierdo et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Wild-Type MIC Distributions and Epidemiological Cutoff Values for Caspofungin and Aspergillus spp. for the CLSI Broth Microdilution Method (M38-A2 Document)
- (2011) A. Espinel-Ingroff et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Cryptic Species and Azole Resistance in the Aspergillus niger Complex
- (2011) Susan J. Howard et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Polyphasic Identification and Susceptibility to Seven Antifungals of 102 Aspergillus Isolates Recovered from Immunocompromised Hosts in Greece
- (2011) Michael Arabatzis et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Azole Resistance in Aspergillus fumigatus Isolates from the ARTEMIS Global Surveillance Study Is Primarily Due to the TR/L98H Mutation in thecyp51AGene
- (2011) Shawn R. Lockhart et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- A prospective survey of Aspergillus spp. in respiratory tract samples: prevalence, clinical impact and antifungal susceptibility
- (2011) K. L. Mortensen et al. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
- Comparison of the activities of amphotericin B, itraconazole, and voriconazole against clinical and environmental isolates of Aspergillus species
- (2011) Richa Misra et al. Indian Journal of Pathology and Microbiology
- Environmental Study of Azole-Resistant Aspergillus fumigatus and Other Aspergilli in Austria, Denmark, and Spain
- (2010) K. L. Mortensen et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Wild-Type MIC Distributions and Epidemiological Cutoff Values for the Triazoles and Six Aspergillus spp. for the CLSI Broth Microdilution Method (M38-A2 Document)
- (2010) A. Espinel-Ingroff et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Use of Epidemiological Cutoff Values To Examine 9-Year Trends in Susceptibility of Candida Species to Anidulafungin, Caspofungin, and Micafungin
- (2010) M. Pfaller et al. JOURNAL OF CLINICAL MICROBIOLOGY
- In vitroactivity of nine antifungal agents against clinical isolates ofAspergillus calidoustus
- (2010) Ana Alastruey-Izquierdo et al. MEDICAL MYCOLOGY
- Patterns of Susceptibility of Aspergillus Isolates Recovered from Patients Enrolled in the Transplant-Associated Infection Surveillance Network
- (2009) J. W. Baddley et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Azole resistance in Aspergillus fumigatus: a side-effect of environmental fungicide use?
- (2009) Paul E Verweij et al. LANCET INFECTIOUS DISEASES
- Clinical Isolates of Aspergillus Species Remain Fully Susceptible to Voriconazole in the Post-Voriconazole Era
- (2008) J. Guinea et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Epidemiological Cutoffs and Cross-Resistance to Azole Drugs in Aspergillus fumigatus
- (2008) J. L. Rodriguez-Tudela et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Aspergillus calidoustussp. nov., Causative Agent of Human Infections Previously Assigned toAspergillus ustus
- (2008) János Varga et al. EUKARYOTIC CELL
- Comparativein vitroactivities of posaconazole, voriconazole, itraconazole, and amphotericin B againstAspergillusandRhizopus, and synergy testing forRhizopus
- (2008) Sevtap Arikan et al. MEDICAL MYCOLOGY
- Emergence of Azole Resistance in Aspergillus fumigatus and Spread of a Single Resistance Mechanism
- (2008) Eveline Snelders et al. PLOS MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now